P775: CLINICAL OUTCOMES AND SOCIOECONOMIC FACTORS IN CHRONIC MYELOMONOCYTIC LEUKEMIA IN THE UNITED STATES USING THE NATIONAL CANCER DATABASE: 2004-2017 by N. Mclaughlin, G. Ruan, K. Wudhikarn, A. Al-Kali, A. Tefferi, N. Gangat, R. Go, M. Patnaik, M. Shah

Get full text

P544: MOLECULAR PREDICTORS OF RESPONSE AND SURVIVAL IN TREATMENT-NAÏVE PATIENTS WITH ACUTE MYELOID LEUKEMIA FOLLOWING VENETOCLAX AND HYPOMETHYLATING AGENTS by I. Johnson, K. McCullough, F. Farrukh, A. Al-Kali, H. Alkhateeb, K. Begna, A. Mangaonkar, M. Litzow, W. Hogan, M. Shah, M. Patnaik, A. Pardanani, A. Tefferi, N. Gangat

Get full text

European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response by K. H. Begna, J. Kittur, N. Gangat, H. Alkhateeb, M. S. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, A. Pardanani, C. A. Hanson, R. P. Ketterling, A. Tefferi

Get full text

Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with “7+3” by K. H. Begna, X. Xu, N. Gangat, H. Alkhateeb, M. M. Patnaik, A. Al-Kali, M. A. Elliott, W. J. Hogan, M. R. Litzow, C. C. Hook, A. P. Wolanskyj-Spinner, A. Mangaonkar, R. He, A. Pardanani, M. Shah, R. P. Ketterling, A. Tefferi

Get full text